Evaluating the presence of antibodies to HPV as prognostic markers in cervical cancer patients.
Baay
Marc F D
MF
Herbrink
Paul
P
D000914:Antibodies, Viral / Q000097:blood*; D014408:Biomarkers, Tumor / Q000097:blood*; D005260:Female; D006801:Humans; D009856:Oncogene Proteins, Viral / Q000276:immunology*; D050725:Papillomavirus E7 Proteins; D011379:Prognosis; D012097:Repressor Proteins; D002583:Uterine Cervical Neoplasms / Q000473:pathology / Q000821:virology*
D000914:Antibodies, Viral; D014408:Biomarkers, Tumor; C068651:E6 protein, Human papillomavirus type 16; D009856:Oncogene Proteins, Viral; D050725:Papillomavirus E7 Proteins; D012097:Repressor Proteins; C059731:oncogene protein E7, Human papillomavirus type 16